Clinical Trials · NCT00748072

1-deamino 8-d-arginine Vasopressin (DDAVP) in Percutaneous Ultrasound-guided Renal Biopsy

CompletedPhase 4Desmopressin (Approved)
Phase
Phase 4
Recruitment status
Completed
Sponsor
University of Bari
Enrollment
162
Start date
Aug 2008
Locations
1 site, Italy
Primary endpoint
The Primary Outcome Measure Was the Incidence of Post-biopsy Bleeding Complications.
View Desmopressin compound reference